I am delighted that the PSA National Board has re-elected National President Grant Kardachi and Vice-Presidents Claire O’Reilly and Joe Demarte for a further term. This gives your PSA stability in its leadership and in our ability to advocate on behalf of you, our members and this is partially important given the challenging environment the profession faces and the fact that we will have a federal election later this year.
Later this year we will also have two major events running back-to-back – the Global Drug Safety Conference and Exposition and PAC13.
Both of these major conferences are behind held in Brisbane and we have coordinated them so that delegates can attend both to catch up on the latest developments and information from a field of national and international experts.
PAC 13 will run from the 10-13 October and the GDS from 14-16 October and details of these great events are available at the PSA website.
Members will have received an invitation to respond to a survey relating to the Government’s decision to impose a $2000 cap on education expenses. PSA and the pharmacy profession feel this figure is manifestly inadequate and the results of the survey will help us press our argument for this decision to be reviewed. The survey closes on 26 June 2013 and I urge you to complete it so we can present a broad representation of members’ views when we seek to have the decision t re-examined.
The survey is just one example of how PSA engages with members and in the near future we plan to survey members to ascertain issues and priorities which you want us, as your representative body, to address and pursue. Your responses will help shape PSA’s operational plans and you will be hearing more about this survey shortly.